Product Refinements Can Bring Product Liability: Bayer's Yaz And Yasmin Hit With Wave of Personal Injury Suits
Executive Summary
Entering a crowded market with a slight twist on a well-established product is often a successful strategy. But Bayer is learning what Johnson & Johnson learned: modest changes to hormonal birth control products can produce lawsuits as much as they drive sales
You may also be interested in...
Charting The Course Of Product Liability: From Yasmin/Yaz To Actos
Bayer’s birth control pills Yasmin and Yaz face the most pharmaceutical product liability actions in federal court followed by Pfizer’s Prempro and GlaxoSmithKline’s Avandia. While GSK has settled the bulk of cases before a single trial, Merck and Novartis are winning Fosamax and Aredia jury verdicts.
Bayer Loses Oversight Of Yaz DTC Ads Under Agreement With States Attorneys General
FDA has oversight over DTC advertising for Bayer’s Yaz contraceptive after the company violated an earlier agreement with state attorneys general.
US Supreme Court Gives PTO Director Chance To Impact Outcome Of Patent Disputes
High court finds PTAB judges were unconstitutionally appointed; ruling is unlikely to benefit one party over another in inter partes review proceedings, attorneys say, but that could depend on the director. PTO is expected to provide guidance on how and when to request review of Patent Trial and Appeal Board decisions.